Hepatocellular carcinoma and hepatitis C in the United States (Q34528514)

2 August 2017

1 reference

title

Hepatocellular carcinoma and hepatitis C in the United States (English)

1 reference

2 August 2017

hepatocellular carcinoma

1 reference

1 reference

United States of America

1 reference

Hashem B El-Serag

1

1 reference

PubMed ID

12407579

2 August 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

2 August 2017

1 reference

2 August 2017

36

1 reference

2 August 2017

5 Suppl 1

1 reference

2 August 2017

S74-83

1 reference

Viruses and hepatocellular carcinoma

2 August 2017

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Correlation between hepatitis C virus prevalence and hepatocellular carcinoma mortality in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

HCV-associated liver cancer without cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Clinical outcomes after transfusion-associated hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Estimating progression to cirrhosis in chronic hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy. Brescia HCC Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Multivariate analysis of risk factors for hepatocellular carcinoma in patients with hepatitis C virus-related liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Roles of alcohol, hepatitis virus infection, and gender in the development of hepatocellular carcinoma in patients with liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

The natural history of chronic hepatitis C in haemophiliacs

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Nonviral Risk Factors for Hepatocellular Carcinoma in a Low-Risk Population, the Non-Asians of Los Angeles County, California

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Diabetes mellitus and the risk of primary liver cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Excess risk of primary liver cancer in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Role of diabetes mellitus in the etiology of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

A case-control study of primary hepatocellular carcinoma in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Correlation of clinicopathologic features of resected hepatocellular carcinoma with hepatitis C virus genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Determinants of outcome of compensated hepatitis C virus-related cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Prevalence of hepatocellular carcinoma and relation to cirrhosis: comparison of two different cities of the world--Trieste, Italy, and Chiba, Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Prognosis of chronic hepatitis C: results of a large, prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Impact of interferon therapy on the natural history of hepatitis C virus related cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Long-term beneficial effects in sustained responders to interferon-alfa therapy for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Treatment of hepatitis C virus-related cirrhosis: a randomized, controlled trial of interferon alfa-2b versus no treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Improved survival after variceal hemorrhage over an 11-year period in the Department of Veterans Affairs

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Risk factors for the rising rates of primary liver cancer in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Characteristics of hepatocellular carcinoma in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Prevalence of hepatitis C virus antibodies and hepatitis C virus-RNA in an urban population

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Risk factors in community-acquired chronic hepatitis C virus infection: a case-control study in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Epidemiology of hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Attributable risks for hepatocellular carcinoma in Northern Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

The rise and fall in primary liver cancer mortality in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Hepatocellular carcinoma occurring in nonfibrotic liver: Epidemiologic and histopathologic analysis of 80 French cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Gross Pathologic Types of Hepatocellular Carcinoma in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

Long interval between HCV infection and development of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36807

21 January 2018

Identifiers

DOI

10.1053/JHEP.2002.36807

1 reference

release_44qeba6jd5egnkq6rqx5bdtoku

2 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/44qeba6jd5egnkq6rqx5bdtoku

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

12407579

1 reference

PubMed ID

12407579